论文部分内容阅读
观察老年急性心肌梗塞102例患者溶栓疗法,分为用尿激酶组(16例)和无尿激酶组(86例)。分析两组溶栓疗效。用尿激酶组和无尿激酶组比较,血管再通率分别为62.5％对23.2％(P<0.001),一月死亡率分别为6％对11.6％(P<0.005),出血并发症分别为6％对6.9％(P<0.001)。分析结果显示用尿激酶组明显优于无尿激酶组,血管再通率高,且较血管未通者严重并发症明显减少,明显降低急性期死亡率,出血并发症无明显差异。
Thrombolytic therapy in elderly patients with acute myocardial infarction (102 cases) was divided into two groups: urokinase group (n = 16) and urokinase group (86 cases). Analysis of two groups thrombolytic effect. The rates of recanalization were 62.5% vs 23.2% (P <0.001), and the mortality rates in January were 6% vs 11.6% (P <0.005), respectively. The bleeding complications were 6% versus 6.9% (P <0.001). The results showed that with urokinase group was significantly better than no urokinase group, the high rate of recanalization and serious complications than those with vascular failure significantly reduced significantly reduce mortality in acute phase, bleeding complications no significant difference.